BGI
GPCR icon

B Group Inc’s Structure Therapeutics GPCR Stock Holding History

B Group Inc’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.51M Buy
140,000
+12,500
+10% +$553K 3.53% 10
2026
Q1 		$6.15M Buy
127,500
+37,500
+42% +$2.57M 4.56% 8
2025
Q4 		$6.26M Buy
+90,000
New +$3.67M 4.62% 8

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

B Group Inc's GPCR Position: Q2 2026 in Review

B Group Inc increased its Structure Therapeutics (GPCR) stake by 9.8% in Q2 2026, buying an estimated $553K and bringing the position to 140,000 shares worth $7.51M. The position accounts for 3.53% of the portfolio, ranked #10.

B Group Inc first reported a position in GPCR in Q4 2025 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • B Group Inc held 140,000 shares of Structure Therapeutics worth $7.51M as of Q2 2026.
  • B Group Inc bought 12,500 Structure Therapeutics shares in Q2 2026, an estimated $553K.
  • Structure Therapeutics made up 3.53% of B Group Inc's portfolio in Q2 2026, its #10 holding.
  • B Group Inc first reported a position in Structure Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on B Group Inc's 13F filing for Q2 2026, filed 14 Aug 2026.